ticagrelor
- Product NDC
- 50228-522
- 11-digit product format
- 502280522
- Labeler code
- 50228
- Product ID
- 50228-522_3d85dd4c-b57c-44f8-bb8f-c3f04545c09d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ticagrelor
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ScieGen Pharmaceuticals INC
- Application
- ANDA218962
- Marketing category
- ANDA
- Marketing start
- 2025-10-09
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ticagrelor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TICAGRELOR | 90 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GLH0314RVC |
| Rxcui | 1116635, 1666332 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50228-522-10 | ticagrelor | 1000 in 1 BOTTLE | TABLET | 1000 | | 3 |
| 50228-522-30 | ticagrelor | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
| 50228-522-60 | ticagrelor | 60 in 1 BOTTLE | TABLET | 60 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50228-522-10 | 50228052210 | 1000 TABLET in 1 BOTTLE (50228-522-10) | 1000 tablet | 2025-10-09 | No | No | Historical |
| 50228-522-30 | 50228052230 | 30 TABLET in 1 BOTTLE (50228-522-30) | 30 tablet | 2025-10-09 | No | No | Historical |
| 50228-522-60 | 50228052260 | 60 TABLET in 1 BOTTLE (50228-522-60) | 60 tablet | 2025-10-09 | No | No | Historical |